// App-Quantinova.ai

T1202 2016 AHA : Cost-effectiveness of Anticoagulants for the Management of Suspected Heparin-induced Thrombocytopenia in the US

Researchers

Presenter

  • Yvonne H Huckleberry

Principal Investigators

  • Jason H Karnes

  • Mahdi Gharaibeh

  • Hussam Kutbi

  • Yuval Raz

  • Seongseok Yun

  • Ivo Abraham

  • Brian Erstad

Medical Centers

  • Banner-Univ Medical Ctr, Tucson, AZ

  • University of Arizona, Tucson, AZ

  • Banner-Univ Medical Ctr, Tucson, AZ

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Thrombocytopenia

  • Venous thrombosis

Biomarkers

  • Prostate specific antigen

Drug/Treatment

  • Fondaparinux sodium

  • Bivalirudin

  • Argatroban

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved